youtube_live
Q2 2027 earnings • in 3 days
See detailschevron_right
532321:BOM
Zydus Lifesciences Ltd
₹1,244.00
arrow_upward
+4.89%(+58.00) 1D
Oct 30, 3:51:30 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532321...
Open
₹1,187.25
High
₹1,249.00
Low
₹1,184.55
Mkt. cap
1.24T
Avg. vol.
69.17K
Volume
310.70K
52-wk high
₹1,249.00
52-wk low
₹835.85
No. of employees
30K
Open
₹1,187.25
High
₹1,249.00
Low
₹1,184.55
Mkt. cap
1.24T
Avg. vol.
69.17K
Volume
310.70K
52-wk high
₹1,249.00
52-wk low
₹835.85
No. of employees
30K
News stories
From web sources and news partners
Seeking Alpha
·
31 minutes ago
S&P 500 earnings growth to slow as AI spending loses momentum, Goldman Sachs says
Yahoo Finance
·
1 hour ago
3 Growth Stocks to Buy in November, Even if the Nasdaq-100 Enters a Correction
Hoodline
·
38 minutes ago
OPay IPO Shares Fail to Trade on NYSE After $304M Raise
CNBC
·
1 day ago
Anthropic's path to the Nasdaq just got a lot bumpier
Profile
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company, headquartered in Ahmedabad, India. Primarily engaged in the manufacturing of generic drugs, the company ranked 100th in the Fortune India 500 list in 2020. Wikipedia
About Zydus Lifesciences Ltd